Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors
Array BioPharma Inc. (NASDAQ: ARRY) announced that it has elected Gwen A. Fyfe, M.D., to its Board of Directors. Dr. Fyfe is an oncology biotechnology veteran with more than 20 years of drug development experience.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.